World leader in respiratory healthcare innovation using FRI

About

Fluidda was founded in 2005, focusing on Computational Fluid Dynamics (CFD), a discipline used in the design of aircraft wings. Image processing of CT scans and flow simulations on patient-specific 3D models are combined to provide a unique sensitive tool for phenotyping patients and monitoring the efficacy of novel respiratory drugs.

Through this novel approach, Fluidda developed its proprietary Functional Respiratory Imaging (FRI) technology where advanced engineering tools are applied to improve the diagnosis and monitoring of respiratory diseases. Its head office is located in Belgium (Kontich), with offices in USA (New York and LA) and Portugal (Lisbon).

Team 

The executive officers are an interdisciplinary team of graduates of aerospace or biomedical engineering programs and respiratory clinicians, focusing on the implementation of FRI. At Fluidda, this combined expertise leads to the development of Respiratory Solutions that support the monitoring and diagnoses of respiratory diseases. 

Timeline

2005
2007
2009
2012
2014
2015
2017
2018
2019
2020
2021
2022

2005

Fluidda was founded in 2005. Its Head Office is located in Kontich, Belgium, with subsidiaries in the USA, Portugal and India.

2007

First scientific publication based on FRI technology.

2009

First use of FRI in a clinical trial related to COPD.

2012

Opening Fluidda office in New York. 

2014

First use of FRI in a clinical trial related to IPF.

2015

First use of FRI in a clinical trial related to CF; Opening Fluidda office in Portugal; European Business Award.

2017

Opening Fluidda office in Los Angeles.

2018

FDA letter of support encouraging further development of FRI for the use in bioequivalence studies.

2019

Collaboration with Kreivohealth in Asia/Pacific. Opening Fluidda office in Singapore.

2020

Fluidda’s Broncholab® platform cleared by the FDA

2021

Over 65 scientific publications in peer-reviewed magazines on respiratory research with FRI.

2022

CE certificate issued for Broncholab® platform for use in the EU

ISO 13485:2016 certification issued for Fluidda’s Quality Management System

Board of directors 

Jan De Backer
Jan De Backer

CEO

AxelFunhoff700x700
Axel Funhoff

Board of directors

Prof. Gabriel Krestin
Gabriel Krestin

Board of directors

Wilfried De Backer
Wilfried De Backer

Executive Chair BOD

JakobG
Jakob Glatz

Board of directors

Executive team

Jan De Backer
Jan De Backer

CEO

Ben Lavon
Ben Lavon

CSO

CharlesMussche700x700
Charles Mussche

VP Clinical Applications

Hosein SADAFI
Hosein Sadafi

VP Computational Engineering

Business contact

Hosein SADAFI
Hosein Sadafi

Europe

CharlesMussche700x700
Charles Mussche

US East Coast

Abel - Villanueva700x700
Abel Villanueva

US West Coast

Ernestine_photo700x700
Ernestine Chung

Middle East, Central Asia and APAC

Offices

Fluidda Kontich office

HQ
Kontich, Belgium

FLUIDDA, nv

Groeningenlei 132
2550 Kontich
Belgium
BE0877 160 706
Tel: +32/(0)3 450 87 20
Fax: +32/(0)3 450 87 29
[email protected]

office NY Fluidda

Office
New York, USA

FLUIDDA, Inc

228 East 45th Street
9th Floor – Suite 9E
New York, NY 10017
United States
[email protected]

fluidda_signa

Office
Singapore

FLUIDDA, Inc

Paya Lebar Link
Paya Lebar Quarter 1, #04-01
Singapore 408533
Singapore
[email protected]

Office_Lisbon

Office
Lisbon, Portugal

MiRC, LDA

Medical Imaging Research Corporation
Avenida da igreja 42, 6th floor
1700-239 Lisbon
Portugal
[email protected]